- Filed
- May 15, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2025 · May 15, 2025 | 1.47M sh |
| Cash And Equivalents | Q1 2025 · Mar 31, 2025 | $3.45M |
| Cash And Equivalents | Q1 2025 · Dec 31, 2024 | $1.66M |
| Stockholders Equity | Q1 2025 · Mar 31, 2025 | $4.11M |
| Stockholders Equity | Q1 2025 · Dec 31, 2024 | $4.04M |
| Current Liabilities | Q1 2025 · Mar 31, 2025 | $1.8M |
| Current Liabilities | Q1 2025 · Dec 31, 2024 | $1.66M |
| Total Liabilities | Q1 2025 · Mar 31, 2025 | $1.95M |
| Total Liabilities | Q1 2025 · Dec 31, 2024 | $1.8M |
| Current Assets | Q1 2025 · Mar 31, 2025 | $5.65M |
| Current Assets | Q1 2025 · Dec 31, 2024 | $5.39M |
| Total Assets | Q1 2025 · Mar 31, 2025 | $5.98M |
| Total Assets | Q1 2025 · Dec 31, 2024 | $5.76M |
| Short Term Investments | Q1 2025 · Dec 31, 2024 | $1.73M |
| Shares Diluted restated | Q1 2025 · Mar 31, 2024 | 168.76K sh |
| Operating Cash Flow | Q1 2025 · Mar 31, 2024 | −$1.14M |
| Eps Diluted restated | Q1 2025 · Mar 31, 2024 | $1.83 |
| Eps Basic restated | Q1 2025 · Mar 31, 2024 | $1.83 |
| Sga Expense | Q1 2025 · Mar 31, 2024 | $1.08M |
| Rd Expense | Q1 2025 · Mar 31, 2024 | $337.18K |
| Net Income | Q1 2025 · Mar 31, 2024 | $430.47K |
| Operating Income restated | Q1 2025 · Mar 31, 2024 | −$1.34M |
| Gross Profit restated | Q1 2025 · Mar 31, 2024 | $40.24K |
| Cost Of Revenue | Q1 2025 · Mar 31, 2024 | $65.44K |
| Revenue restated | Q1 2025 · Mar 31, 2024 | $105.67K |